PerkinElmer Acquires Labtronics Inc.
News May 22, 2011
The addition of Labtronics’ solutions extends PerkinElmer’s ELN and data integration software offerings into laboratories following strict routine procedures, such as regulated and non-regulated QA/QC, late stage product or method development laboratories, and environmental and food testing labs. Labtronics tools can be applied to any procedure-based problem, including laboratory analysis, equipment calibration and validation, cleaning validation and others.
Founded in 1986, Labtronics’ products include its Nexxis ELN™ (Electronic Laboratory Notebook) for quality control (QC) and R&D; and its Nexxis iLAB™ laboratory automation platform. The company is a leader in lab connectivity, directly connecting data from instrumentation to a lab’s ELN, SDMS, LIMS, ERP and SAP technologies for complete interface solutions. Labtronics’ LimsLink™ fully configurable lab integration software platform speeds deployment of new informatics systems and enhances the capabilities of existing system investments.
“We welcome the addition of Labtronics to PerkinElmer’s growing portfolio of informatics and software solutions for laboratory environments, as we enhance the Company’s strategic focus on enterprise-wide knowledge sharing and access,” said Dusty Tenney, president, Analytical Sciences and Laboratory Services, PerkinElmer, Inc. “This acquisition successfully positions PerkinElmer as the only technology provider able to deploy an optimized ELN solution across a global customer’s entire value chain, from research to manufacturing.”
He added, “The acquisition presents strong synergies with our OneSource® Laboratory Services portfolio providing enterprise-level solutions that foster long term partnerships with customers.”
Sysmex Partners with Laboratories to Deliver Improved QC ManagementNews
Sysmex America has announced its latest innovation: a way to make quality assurance easier and more risk free than manual quality control processes.READ MORE
BMS, QIAGEN Partner to Develop Gene Expression Profiles for Immuno-OncologyNews
QIAGEN and Bristol-Myers Squibb intend to develop GEPs for several Bristol-Myers Squibb I-O molecules under the initial agreement.READ MORE
Comments | 0 ADD COMMENT
EMBL Course: Introduction to Next Generation Sequencing
Apr 09 - Apr 12, 2018
EMBL Course: RNA Sequencing Library Preparation - How Low Can You Go?
Mar 19 - Mar 23, 2018
EMBL Course: Analysis and Integration of Transcriptome and Proteome Data
Mar 12 - Mar 16, 2018
EMBO | EMBL Symposium: Tissue Self-Organisation: Challenging the Systems
Mar 11 - Mar 14, 2018